speb/financial-data huggingface dataset:
Financial ratios for PIC.AX — annual report dated 2024-06-30
Total revenue: 27722000
Net income: 19037333.333333332
Capital expenditures: 0
Net tangible assets: 322366666.6666667
Owner earnings: 19037333.333333332
Return on net tangible assets (%): 5.905490642125943
Buffett classification: The Gruesome
Stock price: 0.7200000000000001
P/E ratio: 14.570862850539294
Shares outstanding: 385264407
Book value: 322366666.6666666
P/B ratio: 0.8604809421156036
Market cap (USD): 277390373.04
Debt to equity: 0
Effective tax rate (%): 20.423575310018112
COGS to revenue (%): 0
SG&A to revenue (%): 0.5699444484524926
Free cash flow (dilution-adjusted): 1833333.3333333333
Buyback yield (%): 0
Retained earnings: -6248666.666666667
Receivables turnover: 3.5656834162236324
Capitalized R&D asset: 0
FCF margin (%): 6.613279465166053
Revenue growth (%): -47.24344012300556
Rule of 40 score: -40.63016065783951
Financial ratios for PRICOLLTD.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.710536726889094
Shares outstanding: 121881498
Market cap (USD): 208482778.65725967
Buyback yield (%): 0
Retained earnings: -44433838.850059345
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRICOLLTD.NS — annual report dated 2023-03-31
Total revenue: 231769939.0986602
Gross profit: 64154409.25700366
Operating income: 18559451.887941536
Net income: 15187003.65408039
Capital expenditures: 10255834.348355664
Operating cash flow: 19828672.35079172
Depreciation & amortization: 9489378.80633374
Net tangible assets: 66239366.626065776
Owner earnings: 14420548.112058466
Return on net tangible assets (%): 21.77035929927484
Capex to operating income (%): 55.259360083899324
Buffett classification: The Good
Stock price: 2.515834348355664
P/E ratio: 20.190530408877393
Shares outstanding: 121881498
Book value: 85783520.09744214
P/B ratio: 3.5745054382139454
Market cap (USD): 306633659.0974422
Debt to equity: 0.1566531451077813
Current ratio: 1.3140767133876203
Quick ratio: 0.7761722344801588
Effective tax rate (%): 14.960237348247169
Interest coverage ratio: 8.523367884052782
COGS to revenue (%): 72.31978853405388
SG&A to revenue (%): 3.023562993921899
Free cash flow (dilution-adjusted): 9488952.496954933
Buyback yield (%): 0
Retained earnings: -25853410.475030452
Inventory turnover: 5.065251590846852
Receivables turnover: 7.074271569798546
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.988833118383504
FCF margin (%): 4.094125637628813
Rule of 40 score: 4.094125637628813
Financial ratios for PRICOLLTD.NS — annual report dated 2024-03-31
Total revenue: 264800203.86137426
Gross profit: 77929152.17651996
Operating income: 24558076.507974576
Net income: 16861913.898548987
Capital expenditures: 16498261.18239597
Operating cash flow: 30552500.299796138
Depreciation & amortization: 9840580.405324379
Net tangible assets: 84767897.82947595
Owner earnings: 10204233.121477397
Return on net tangible assets (%): 12.037850864256216
Capex to operating income (%): 67.18059200214074
Buffett classification: The Good
Stock price: 4.655470249520153
P/E ratio: 33.65072857801615
Shares outstanding: 121881498
Book value: 101363724.66722628
P/B ratio: 5.597818053438316
Market cap (USD): 567415687.9059501
Debt to equity: 0.0720280487194597
Current ratio: 1.413116491495823
Quick ratio: 0.8039620856469972
Effective tax rate (%): 24.36362521422278
Interest coverage ratio: 11.298747586206895
COGS to revenue (%): 70.5705845236748
SG&A to revenue (%): 3.1536038751383555
Free cash flow (dilution-adjusted): 13368041.731622497
Buyback yield (%): 0
Retained earnings: -7821993.044729584
Inventory turnover: 4.865713393595929
Receivables turnover: 7.692877351539346
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.507225366027146
FCF margin (%): 5.048350241686675
Revenue growth (%): 14.251315287550593
Rule of 40 score: 19.299665529237267
Financial ratios for PRICOLLTD.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 96857345.91495462
Buffett classification: The Gruesome
Stock price: 5.694935499283325
Shares outstanding: 121881498
Book value: 112032644.52938366
P/B ratio: 6.19558051656971
Market cap (USD): 694107269.6660296
Debt to equity: 0.05780738222053862
Current ratio: 1.4331042067355824
Quick ratio: 0.8922594983654105
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRICOLLTD.NS — quarterly report dated 2024-12-31
Total revenue: 71792749.73773167
Gross profit: 20798461.359132763
Operating income: 6142907.098729455
Net income: 4831565.450518708
Capital expenditures: 0
Depreciation & amortization: 2611026.9262151765
Owner earnings: 7442592.376733884
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.309126937871547
P/E ratio: 39.788648737925215
Shares outstanding: 121881498
Market cap (USD): 768965842.259937
Effective tax rate (%): 23.875114784205692
Interest coverage ratio: 23.422222222222224
COGS to revenue (%): 71.0298582585118
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRICOLLTD.NS — annual report dated 2025-03-31
Total revenue: 306395838.2043488
Gross profit: 88172784.66214636
Operating income: 27097264.437689967
Net income: 19526537.292494737
Capital expenditures: 22984568.622866493
Operating cash flow: 26119943.885901332
Depreciation & amortization: 10492167.407061024
Net tangible assets: 103336450.78325929
Owner earnings: 7034136.076689269
Return on net tangible assets (%): 6.807023101115462
Capex to operating income (%): 84.82246861383148
Buffett classification: The Gruesome
Stock price: 5.250554323725056
P/E ratio: 32.773113671923674
Shares outstanding: 121881498
Book value: 118778349.3102642
P/B ratio: 5.3877278984099
Market cap (USD): 639945426.3059868
Debt to equity: 0.2744505575622767
Current ratio: 1.2108025987500308
Quick ratio: 0.7629011141029125
Effective tax rate (%): 26.291867084418165
Interest coverage ratio: 17.653465346534656
COGS to revenue (%): 71.22259062691967
SG&A to revenue (%): 2.7082196641624474
Free cash flow (dilution-adjusted): 837035.3051204114
Buyback yield (%): 0
Retained earnings: 11900865.092354454
Inventory turnover: 5.147616027355707
Receivables turnover: 5.544083428523078
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.33709442504431
FCF margin (%): 0.27318755699356334
Revenue growth (%): 15.708309033157054
Rule of 40 score: 15.981496590150616
Financial ratios for PRICOLLTD.NS — quarterly report dated 2025-03-31
Total revenue: 87913256.95581014
Gross profit: 25950432.546177223
Operating income: 6277764.788403085
Net income: 4085807.8092120644
Capital expenditures: 0
Depreciation & amortization: 3080430.2080897824
Net tangible assets: 103336450.78325929
Owner earnings: 7166238.017301846
Return on net tangible assets (%): 6.934859832115301
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.250554323725056
P/E ratio: 39.15660355237061
Shares outstanding: 121881498
Book value: 118778349.3102642
P/B ratio: 5.3877278984099
Market cap (USD): 639945426.3059868
Debt to equity: 0.2744505575622767
Current ratio: 1.2108025987500308
Quick ratio: 0.7629011141029125
Effective tax rate (%): 33.85692657077971
Interest coverage ratio: 10.326923076923077
COGS to revenue (%): 70.4817755083044
Buyback yield (%): 0
Retained earnings: 11900865.092354454
Inventory turnover: 1.4616275542564046
Receivables turnover: 1.590747556796548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.711600891431378
Revenue growth (%): 22.454227309817227
Rule of 40 score: 22.454227309817227
Financial ratios for PRICOLLTD.NS — quarterly report dated 2025-06-30
Total revenue: 102698385.20945473
Gross profit: 29666920.1965832
Operating income: 8228703.487011468
Net income: 5838251.813714019
Capital expenditures: 0
Depreciation & amortization: 3351802.0126374913
Owner earnings: 9190053.82635151
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.3451907325064365
P/E ratio: 44.1512880905363
Shares outstanding: 121881498
Market cap (USD): 651479853.5736017
Effective tax rate (%): 24.57182681681641
Interest coverage ratio: 10.951442854250697
COGS to revenue (%): 71.11257383835478
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 16.817859746768764
Rule of 40 score: 16.817859746768764
Financial ratios for PRICOLLTD.NS — quarterly report dated 2025-12-31
Total revenue: 113663807.5080762
Gross profit: 33770747.4657458
Operating income: 10159295.97861201
Net income: 7094797.816642531
Capital expenditures: 0
Depreciation & amortization: 3364152.8350228365
Owner earnings: 10458950.651665367
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.364375626601315
P/E ratio: 41.07843302255053
Shares outstanding: 121881498
Market cap (USD): 897581133.2048569
Effective tax rate (%): 24.627218934911244
Interest coverage ratio: 10.604651162790697
COGS to revenue (%): 70.28891763691246
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.677307414578477
Rule of 40 score: 10.677307414578477
Financial ratios for QGEN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 54.85
Shares outstanding: 206250000
Market cap (USD): 11312812500
Buyback yield (%): 1.0043620090856356
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QGEN — annual report dated 2022-12-31
Total revenue: 2278210638.2978725
Gross profit: 1472939361.7021277
Operating income: 613008510.6382979
Net income: 450224468.08510643
Capital expenditures: 137472340.42553192
Operating cash flow: 760919148.9361702
Depreciation & amortization: 221698936.17021278
Net tangible assets: 605580851.0638298
Owner earnings: 534451063.8297873
Return on net tangible assets (%): 88.25428725015198
Capex to operating income (%): 22.425845325114363
Buffett classification: The Great
Stock price: 49.22
P/E ratio: 22.547919359373928
Shares outstanding: 206250000
Book value: 3687884042.5531917
P/B ratio: 2.7526963654127905
Market cap (USD): 10151625000
Debt to equity: 0.543375071503552
Current ratio: 2.4565371981985034
Quick ratio: 2.089219033311682
Effective tax rate (%): 17.438514556155763
Interest coverage ratio: 9.874188186507189
COGS to revenue (%): 35.34665597020431
R&D to revenue (%): 8.865627092557709
SG&A to revenue (%): 28.201724197508494
Free cash flow (dilution-adjusted): 549384042.5531915
Buyback yield (%): 0
Retained earnings: 2298056382.9787235
Inventory turnover: 2.1146357134875404
Receivables turnover: 4.933600265396205
Capitalized R&D asset: 201977659.5744681
ROCI (R&D-adjusted, %): 12.77106304219347
FCF margin (%): 24.114716756992003
Rule of 40 score: 24.114716756992003
Financial ratios for QGEN — annual report dated 2023-12-31
Total revenue: 2183678888.888889
Gross profit: 1370764444.4444444
Operating income: 494718888.8888889
Net income: 379225555.5555555
Capital expenditures: 166344444.44444445
Operating cash flow: 510505555.5555555
Depreciation & amortization: 228151111.1111111
Net tangible assets: 894678888.8888888
Owner earnings: 441032222.2222222
Return on net tangible assets (%): 49.29502950158406
Capex to operating income (%): 33.624033401684905
Buffett classification: The Good
Stock price: 42.86
P/E ratio: 23.310335684128184
Shares outstanding: 206250000
Book value: 4230848888.888889
P/B ratio: 2.089385660455848
Market cap (USD): 8839875000
Debt to equity: 0.4023521415717991
Current ratio: 1.9897840530791917
Quick ratio: 1.6206674183933372
Effective tax rate (%): 20.59193734891545
Interest coverage ratio: 8.336397678337391
COGS to revenue (%): 37.226830766224786
R&D to revenue (%): 10.10074232526048
SG&A to revenue (%): 29.469432573267028
Free cash flow (dilution-adjusted): 277281111.1111111
Buyback yield (%): 0
Retained earnings: 2729777777.7777777
Inventory turnover: 1.8364722567365739
Receivables turnover: 3.8113791906415875
Capitalized R&D asset: 355892809.6926714
ROCI (R&D-adjusted, %): 9.652259395851008
Rosenberg metric: -0.5058723696123032
FCF margin (%): 12.697888527566375
Revenue growth (%): -4.149385830258941
Rule of 40 score: 8.548502697307434
Financial ratios for QGEN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.93
Shares outstanding: 206250000
Market cap (USD): 9266812500
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QGEN — annual report dated 2024-12-31
Total revenue: 2060639583.3333335
Gross profit: 1007656250
Operating income: 208228125
Net income: 87073958.33333334
Capital expenditures: 174139583.33333334
Operating cash flow: 701615625
Depreciation & amortization: 211737500
Net tangible assets: 873027083.3333334
Owner earnings: 124671875.00000003
Return on net tangible assets (%): 14.28041321742119
Capex to operating income (%): 83.62923276254509
Buffett classification: The Gruesome
Stock price: 43.9
P/E ratio: 103.98487875488988
Shares outstanding: 206250000
Book value: 3715978125.0000005
P/B ratio: 2.4366061089232054
Market cap (USD): 9054375000
Debt to equity: 0.42399699047385175
Current ratio: 1.8808010510243935
Quick ratio: 1.612809023915795
Effective tax rate (%): 31.00035494069189
Interest coverage ratio: 4.559635957209005
COGS to revenue (%): 51.0998304531259
R&D to revenue (%): 9.781247124931882
SG&A to revenue (%): 28.528814374986734
Free cash flow (dilution-adjusted): 477793750
Buyback yield (%): 3.3604726076252276
Retained earnings: 2550127083.3333335
Inventory turnover: 3.6198470220872605
Receivables turnover: 4.309994052067288
Capitalized R&D asset: 415989288.77068555
ROCI (R&D-adjusted, %): 3.837581435947033
Rosenberg metric: -1.6462431552911425
FCF margin (%): 23.186672422700475
Revenue growth (%): -5.634496270564802
Rule of 40 score: 17.552176152135672
Financial ratios for QGEN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.9
Shares outstanding: 206250000
Market cap (USD): 9054375000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QGEN — quarterly report dated 2025-03-31
Total revenue: 525495652.173913
Gross profit: 335522826.0869565
Operating income: 136046739.13043478
Net income: 98650000
Capital expenditures: 47719565.217391305
Operating cash flow: 151891304.3478261
Depreciation & amortization: 47726086.956521735
Net tangible assets: 726877173.9130435
Owner earnings: 98656521.73913044
Return on net tangible assets (%): 13.572653713697816
Capex to operating income (%): 35.07586107715539
Buffett classification: The Good
Stock price: 39.58
P/E ratio: 20.68772174353776
Shares outstanding: 206250000
Book value: 3704214130.4347825
P/B ratio: 2.2038075317859183
Market cap (USD): 8163375000
Debt to equity: 0.4132599269281139
Current ratio: 3.371488981398372
Quick ratio: 2.8272056547711166
Effective tax rate (%): 24.083011986716745
Interest coverage ratio: 17.15972031806965
COGS to revenue (%): 36.15116990998147
R&D to revenue (%): 9.056253309504898
SG&A to revenue (%): 28.53248279057453
Free cash flow (dilution-adjusted): 90366304.3478261
Buyback yield (%): 0
Retained earnings: 2716276086.9565215
Inventory turnover: 0.6211704411367481
Receivables turnover: 1.418982935434069
Capitalized R&D asset: 47590217.391304344
ROCI (R&D-adjusted, %): 3.0430862982485474
FCF margin (%): 17.196394294413558
Rule of 40 score: 17.196394294413558
Financial ratios for QGEN — quarterly report dated 2025-06-30
Total revenue: 627694117.6470588
Gross profit: 393277647.0588235
Operating income: 159969411.7647059
Net income: 113235294.11764707
Capital expenditures: 47282352.941176474
Operating cash flow: 189923529.4117647
Depreciation & amortization: 58209411.76470588
Net tangible assets: 752068235.2941177
Owner earnings: 124162352.94117647
Return on net tangible assets (%): 16.509453147242585
Capex to operating income (%): 29.557121214349802
Buffett classification: The Good
Stock price: 47.38
P/E ratio: 46.11988312211103
Shares outstanding: 206250000
Book value: 4124105882.352941
P/B ratio: 2.369513605801186
Market cap (USD): 9772125000
Debt to equity: 0.4119355639297217
Current ratio: 1.6121301339875247
Quick ratio: 1.352849472753152
Effective tax rate (%): 24.10562919390322
Interest coverage ratio: 17.879552925706776
COGS to revenue (%): 37.34565355924579
R&D to revenue (%): 8.949657007909435
SG&A to revenue (%): 27.878884432282486
Free cash flow (dilution-adjusted): 129225882.35294119
Buyback yield (%): 0
Retained earnings: 2962311764.7058825
Inventory turnover: 0.6810938301145103
Receivables turnover: 1.3830951010737302
Capitalized R&D asset: 88061916.24040921
ROCI (R&D-adjusted, %): 3.2350910313197345
Rosenberg metric: 1.2135859875777737
FCF margin (%): 20.58739738351389
Revenue growth (%): 19.448013518354138
Rule of 40 score: 40.035410901868026
Financial ratios for QGEN — quarterly report dated 2025-09-30
Total revenue: 626568235.2941177
Gross profit: 389716470.5882353
Operating income: 161521176.47058824
Net income: 152991764.70588237
Capital expenditures: 54170588.23529412
Operating cash flow: 194140000
Depreciation & amortization: 59960000
Net tangible assets: 938542352.9411765
Owner earnings: 158781176.47058827
Return on net tangible assets (%): 16.917848829411316
Capex to operating income (%): 33.53776230397762
Buffett classification: The Good
Stock price: 44.28
P/E ratio: 25.029663496649153
Shares outstanding: 206250000
Book value: 4293429411.764706
P/B ratio: 2.127145720615496
Market cap (USD): 9132750000
Debt to equity: 0.5828857501818785
Current ratio: 2.6000862950159496
Quick ratio: 2.301930850981863
Effective tax rate (%): 3.475943767350029
Interest coverage ratio: 16.706376247262106
COGS to revenue (%): 37.80143188948953
R&D to revenue (%): 9.153127305978598
SG&A to revenue (%): 26.87017798164793
Free cash flow (dilution-adjusted): 122191764.70588237
Buyback yield (%): 0
Retained earnings: 3114792941.1764708
Inventory turnover: 0.6936800975791281
Receivables turnover: 1.4180960800080946
Capitalized R&D asset: 110693595.2685422
ROCI (R&D-adjusted, %): 2.4742089002166154
Rosenberg metric: -0.06339267015706757
FCF margin (%): 19.501749023156954
Revenue growth (%): -0.17936799490197214
Rule of 40 score: 19.32238102825498
Financial ratios for QGEN — annual report dated 2025-12-31
Total revenue: 2458822352.9411764
Gross profit: 1528817647.0588236
Operating income: 612129411.7647059
Net income: 499858823.5294118
Capital expenditures: 236528235.29411766
Operating cash flow: 769795294.117647
Depreciation & amortization: 227936470.5882353
Net tangible assets: 813017647.0588236
Owner earnings: 491267058.82352936
Return on net tangible assets (%): 60.4251409057035
Capex to operating income (%): 38.640233706828624
Buffett classification: The Good
Stock price: 44.57
P/E ratio: 18.390317560252306
Shares outstanding: 206250000
Book value: 4444887058.823529
P/B ratio: 2.0681206020188694
Market cap (USD): 9192562500
Debt to equity: 0.47969775715865476
Current ratio: 3.895584579907329
Quick ratio: 3.3061173084545734
Effective tax rate (%): 13.336664864919992
Interest coverage ratio: 15.645597786865528
COGS to revenue (%): 37.82317599195024
R&D to revenue (%): 8.972061709120435
SG&A to revenue (%): 27.92675977356927
Free cash flow (dilution-adjusted): 466823529.4117647
Buyback yield (%): 0
Retained earnings: 3233400000
Inventory turnover: 2.6185340258638967
Receivables turnover: 4.0189737958937215
Capitalized R&D asset: 428437112.9901961
ROCI (R&D-adjusted, %): 8.571596470653779
Rosenberg metric: 2.5856871074889693
FCF margin (%): 18.985655017059816
Revenue growth (%): 19.323261225708098
Rule of 40 score: 38.308916242767914
Financial ratios for QGEN — quarterly report dated 2025-12-31
Total revenue: 635788235.2941177
Gross profit: 382669411.7647059
Operating income: 143388235.29411766
Net income: 126857647.05882353
Capital expenditures: 83425882.35294119
Operating cash flow: 221331764.70588237
Depreciation & amortization: 58110588.23529412
Net tangible assets: 813017647.0588236
Owner earnings: 101542352.94117644
Return on net tangible assets (%): 12.489563210407121
Capex to operating income (%): 58.18181818181818
Buffett classification: The Good
Stock price: 44.57
P/E ratio: 18.694150301035112
Shares outstanding: 206250000
Book value: 4444887058.823529
P/B ratio: 2.0681206020188694
Market cap (USD): 9192562500
Debt to equity: 0.47969775715865476
Current ratio: 3.895584579907329
Quick ratio: 3.3061173084545734
Effective tax rate (%): 1.2274546803579771
Interest coverage ratio: 12.020909359897425
COGS to revenue (%): 39.811813034306645
R&D to revenue (%): 8.740424114577552
SG&A to revenue (%): 28.473409570334184
Free cash flow (dilution-adjusted): 117597647.05882353
Buyback yield (%): 0
Retained earnings: 3233400000
Inventory turnover: 0.712684836760653
Receivables turnover: 1.0392032813302232
Capitalized R&D asset: 112533717.64705883
ROCI (R&D-adjusted, %): 2.066652929675592
Rosenberg metric: -0.12287683597275804
FCF margin (%): 18.49635468709522
Revenue growth (%): 1.4715077274340338
Rule of 40 score: 19.967862414529254
Financial ratios for RCN.L — annual report dated 2022-03-31
Total revenue: 122800000
Gross profit: 78355263.15789473
Operating income: 8693421.05263158
Net income: 9131578.94736842
Capital expenditures: 2978947.3684210526
Operating cash flow: 22913157.89473684
Depreciation & amortization: 18810526.315789472
Net tangible assets: 5423684.2105263155
Owner earnings: 24963157.89473684
Return on net tangible assets (%): 460.2620087336245
Capex to operating income (%): 34.26668684728318
Buffett classification: The Good
Stock price: 0.013684210526315788
P/E ratio: 0.2387522859942363
Shares outstanding: 159321237
Book value: 94536842.10526316
P/B ratio: 0.02306175349070259
Market cap (USD): 2180185.3484210526
Debt to equity: 0.25677819841888433
Current ratio: 0.8477016304529781
Quick ratio: 0.8010646489671566
Effective tax rate (%): -25.36127167630057
Interest coverage ratio: 6.169000933706816
COGS to revenue (%): 36.19278244471113
Free cash flow (dilution-adjusted): 17721052.63157895
Buyback yield (%): 160.89892262520775
Retained earnings: 13882894.736842105
Inventory turnover: 24.2483847810481
Receivables turnover: 9.124755572937035
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.375036277989865
FCF margin (%): 14.430824618549632
Rule of 40 score: 14.430824618549632
Financial ratios for RCN.L — annual report dated 2023-03-31
Total revenue: 174906172.83950615
Gross profit: 124581481.48148148
Operating income: -11144444.444444444
Net income: -11419753.086419752
Capital expenditures: 6796296.296296296
Operating cash flow: 17474074.074074075
Depreciation & amortization: 29661728.395061728
Net tangible assets: -30896296.296296295
Owner earnings: 11445679.012345683
Buffett classification: The Gruesome
Stock price: 0.015679012345679012
Shares outstanding: 159321237
Book value: 71840740.74074072
P/B ratio: 0.03477135141001187
Market cap (USD): 2497999.6418518517
Debt to equity: 1.2773452939457997
Current ratio: 0.7436000536121163
Quick ratio: 0.6813429835142742
Interest coverage ratio: -2.786971287434393
COGS to revenue (%): 28.77239295848215
Free cash flow (dilution-adjusted): 8054320.987654321
Buyback yield (%): 0
Retained earnings: -6025925.925925925
Inventory turnover: 10.969590958019376
Receivables turnover: 7.011828755258598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.817872841799974
FCF margin (%): 4.604938097322021
Revenue growth (%): 42.43173683998872
Rule of 40 score: 47.03667493731074
Financial ratios for RCN.L — annual report dated 2024-03-31
Total revenue: 157941772.15189874
Gross profit: 99020253.16455695
Operating income: 7784810.126582278
Net income: -4355696.202531645
Capital expenditures: 11727848.101265822
Operating cash flow: 29094936.70886076
Depreciation & amortization: 30222784.81012658
Net tangible assets: -30886075.949367087
Owner earnings: 14139240.506329115
Capex to operating income (%): 150.65040650406502
Buffett classification: The Gruesome
Stock price: 0.015569620253164556
Shares outstanding: 159321237
Book value: 68965822.78481013
P/B ratio: 0.035968122443698035
Market cap (USD): 2480571.1583544305
Debt to equity: 1.3856615825119762
Current ratio: 0.7705186636031489
Quick ratio: 0.6916644694715431
Effective tax rate (%): 5.949781659388647
Interest coverage ratio: 1.6844700082169268
COGS to revenue (%): 37.3058489749467
SG&A to revenue (%): 2.8130860595957485
Free cash flow (dilution-adjusted): 14054430.379746836
Buyback yield (%): 0
Retained earnings: -14040506.329113923
Inventory turnover: 11.11726773346071
Receivables turnover: 6.8594832325453545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.6800803604042365
FCF margin (%): 8.898488467148605
Revenue growth (%): -9.699143496309839
Rule of 40 score: -0.8006550291612342
Financial ratios for RCN.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -28470666.666666668
Buffett classification: The Gruesome
Stock price: 0.017066666666666667
Shares outstanding: 159321237
Book value: 75690666.66666666
P/B ratio: 0.03592361600901917
Market cap (USD): 2719082.4448
Debt to equity: 1.244169250281849
Current ratio: 0.8172735261529056
Quick ratio: 0.7555305085393343
Buyback yield (%): 0
Retained earnings: -11766666.666666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RCN.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 22111688.31168831
Buffett classification: The Gruesome
Stock price: 0.016103896103896103
Shares outstanding: 159321237
Book value: 69420779.22077921
P/B ratio: 0.036958568840498376
Market cap (USD): 2565692.6477922075
Debt to equity: 0.8504882702884725
Current ratio: 1.572415747776443
Quick ratio: 1.538552899734118
Buyback yield (%): 0
Retained earnings: -16048051.948051948
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RCN.L — annual report dated 2025-03-31
Total revenue: 175503896.1038961
Gross profit: 108157142.85714285
Operating income: 12101298.7012987
Net income: 4529870.12987013
Capital expenditures: 12550649.350649351
Operating cash flow: 38657142.85714286
Depreciation & amortization: 27222077.92207792
Net tangible assets: 22111688.31168831
Owner earnings: 19201298.7012987
Return on net tangible assets (%): 86.8377775167391
Capex to operating income (%): 103.7132431852329
Buffett classification: The Gruesome
Stock price: 0.016103896103896103
P/E ratio: 0.5663943058486238
Shares outstanding: 159321237
Book value: 69420779.22077921
P/B ratio: 0.036958568840498376
Market cap (USD): 2565692.6477922075
Debt to equity: 0.8504882702884725
Current ratio: 1.572415747776443
Quick ratio: 1.538552899734118
Effective tax rate (%): 38.59489051094891
Interest coverage ratio: 2.510913500404204
COGS to revenue (%): 38.37336648463052
SG&A to revenue (%): 2.9303378768370107
Free cash flow (dilution-adjusted): 22255844.155844156
Buyback yield (%): 0
Retained earnings: -16048051.948051948
Inventory turnover: 20.66839378238342
Receivables turnover: 8.17581220884506
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.378585663385469
FCF margin (%): 12.681111160443399
Revenue growth (%): 11.119366151664547
Rule of 40 score: 23.800477312107944
Financial ratios for S — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.75
Shares outstanding: 336745012
Market cap (USD): 15069339287
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for S — annual report dated 2023-01-31
Total revenue: 422179000
Gross profit: 278002000
Operating income: -402576000
Net income: -378678000
Capital expenditures: 4953000
Operating cash flow: -193287000
Depreciation & amortization: 29721000
Net tangible assets: 971304000
Owner earnings: -353910000
Return on net tangible assets (%): -36.43658422080008
Buffett classification: The Gruesome
Stock price: 15.09
Shares outstanding: 336745012
Book value: 1656705000
P/B ratio: 3.0672221252908636
Market cap (USD): 5081482231.08
Debt to equity: 0.016281715815428817
Current ratio: 1.932756365695499
Quick ratio: 1.932756365695499
Interest coverage ratio: -219.98688524590165
COGS to revenue (%): 34.150680161732346
R&D to revenue (%): 49.03322998064802
SG&A to revenue (%): 112.17279874176593
Free cash flow (dilution-adjusted): -376565000
Buyback yield (%): 0
Retained earnings: -1000351000
Receivables turnover: 2.7868072241438493
Capitalized R&D asset: 207008000
ROCI (R&D-adjusted, %): -13.277380817360404
FCF margin (%): -89.19557817892411
Rule of 40 score: -89.19557817892411
Financial ratios for S — annual report dated 2024-01-31
Total revenue: 621154000
Gross profit: 441873000
Operating income: -371710000
Net income: -338693000
Capital expenditures: 1304000
Operating cash flow: -68374000
Depreciation & amortization: 38912000
Net tangible assets: 921729000
Owner earnings: -301085000
Return on net tangible assets (%): -32.66524108496098
Buffett classification: The Gruesome
Stock price: 26.8
Shares outstanding: 336745012
Book value: 1594043000
P/B ratio: 5.66155763778016
Market cap (USD): 9024766321.6
Debt to equity: 0.014383551761150734
Current ratio: 2.1986164283039047
Quick ratio: 2.1986164283039047
Interest coverage ratio: -305.6825657894737
COGS to revenue (%): 28.86256870276936
R&D to revenue (%): 35.12430089800597
SG&A to revenue (%): 95.85497316285495
Free cash flow (dilution-adjusted): -304009000
Buyback yield (%): 0
Retained earnings: -1339044000
Receivables turnover: 2.8982279000755873
Capitalized R&D asset: 356871360
ROCI (R&D-adjusted, %): -14.13946910048416
Rosenberg metric: 0.7916167491111454
FCF margin (%): -48.94261326498743
Revenue growth (%): 47.130482567820756
Rule of 40 score: -1.8121306971666726
Financial ratios for S — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.79
Shares outstanding: 336745012
Market cap (USD): 8684653859.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for S — quarterly report dated 2025-01-31
Total revenue: 225521000
Gross profit: 168511000
Operating income: -80258000
Net income: -70788000
Capital expenditures: 194000
Operating cash flow: -3401000
Depreciation & amortization: 10941000
Net tangible assets: 932456000
Owner earnings: -60041000
Return on net tangible assets (%): -6.439016961658245
Buffett classification: The Gruesome
Stock price: 23.95
Shares outstanding: 336745012
Book value: 1669247000
P/B ratio: 4.831545623505689
Market cap (USD): 8065043037.4
Debt to equity: 0.011421317516221385
Current ratio: 1.7434875226753026
Quick ratio: 1.7434875226753026
Interest coverage ratio: -1315.704918032787
COGS to revenue (%): 25.279242287857894
R&D to revenue (%): 33.090488247214225
SG&A to revenue (%): 77.21808612058301
Free cash flow (dilution-adjusted): -83040000
Buyback yield (%): 0
Retained earnings: -1627485000
Receivables turnover: 0.9555488703964206
Capitalized R&D asset: 74626000
ROCI (R&D-adjusted, %): -1.6334189645934905
FCF margin (%): -36.82140465854621
Rule of 40 score: -36.82140465854621
Financial ratios for S — annual report dated 2025-01-31
Total revenue: 821461000
Gross profit: 610355000
Operating income: -329359000
Net income: -288441000
Capital expenditures: 1860000
Operating cash flow: 33728000
Depreciation & amortization: 42766000
Net tangible assets: 932456000
Owner earnings: -247535000
Return on net tangible assets (%): -26.54656091011265
Buffett classification: The Gruesome
Stock price: 23.95
Shares outstanding: 336745012
Book value: 1669247000
P/B ratio: 4.831545623505689
Market cap (USD): 8065043037.4
Debt to equity: 0.011421317516221385
Current ratio: 1.7434875226753026
Quick ratio: 1.7434875226753026
Interest coverage ratio: -1926.076023391813
COGS to revenue (%): 25.698846323806002
R&D to revenue (%): 32.503308130270334
SG&A to revenue (%): 81.89214095373973
Free cash flow (dilution-adjusted): -260939000
Buyback yield (%): 0
Retained earnings: -1627485000
Receivables turnover: 3.4805899700015255
Capitalized R&D asset: 481492560
ROCI (R&D-adjusted, %): -12.885352731718752
Rosenberg metric: 0.7722297594602523
FCF margin (%): -31.765232920369925
Revenue growth (%): 32.24755857645608
Rule of 40 score: 0.48232565608615374
Financial ratios for S — quarterly report dated 2025-04-30
Total revenue: 229029000
Gross profit: 172497000
Operating income: -82316000
Net income: -208193000
Capital expenditures: 146000
Operating cash flow: 52274000
Depreciation & amortization: 10848000
Net tangible assets: 816112000
Owner earnings: -197491000
Return on net tangible assets (%): -24.199006999039348
Buffett classification: The Gruesome
Stock price: 18.5
Shares outstanding: 336745012
Book value: 1546542000
P/B ratio: 4.028201446840758
Market cap (USD): 6229782722
Debt to equity: 0.008120697659682052
Current ratio: 1.7499558519886982
Quick ratio: 1.7499558519886982
COGS to revenue (%): 24.683337044653733
R&D to revenue (%): 31.547533281811475
SG&A to revenue (%): 79.71042968357719
Free cash flow (dilution-adjusted): -23232000
Buyback yield (%): 0
Retained earnings: -1835678000
Receivables turnover: 1.4775111283143023
Capitalized R&D asset: 122252420
ROCI (R&D-adjusted, %): -3.0784657254233543
Rosenberg metric: 0.053413019591027254
FCF margin (%): -10.143693593387738
Revenue growth (%): 1.555509243041668
Rule of 40 score: -8.58818435034607
Financial ratios for S — quarterly report dated 2025-07-31
Total revenue: 242183000
Gross profit: 181709000
Operating income: -76735000
Net income: -72019000
Capital expenditures: 264000
Operating cash flow: -1043000
Depreciation & amortization: 12269000
Net tangible assets: 783878000
Owner earnings: -60014000
Return on net tangible assets (%): -7.656038312084279
Buffett classification: The Gruesome
Stock price: 18.34
Shares outstanding: 336745012
Book value: 1507786000
P/B ratio: 4.096008001188497
Market cap (USD): 6175903520.08
Debt to equity: 0.007655595687982247
Current ratio: 1.8310019169671703
Quick ratio: 1.8310019169671703
COGS to revenue (%): 24.97037364307156
R&D to revenue (%): 32.65753583034317
SG&A to revenue (%): 74.05680828134096
Free cash flow (dilution-adjusted): -81111000
Buyback yield (%): 0
Retained earnings: -1907697000
Receivables turnover: 1.3504728659692637
Capitalized R&D asset: 152127090
ROCI (R&D-adjusted, %): -3.828627865873396
Rosenberg metric: 0.12749643613413975
FCF margin (%): -33.49161584421697
Revenue growth (%): 5.743377476214802
Rule of 40 score: -27.74823836800217
Financial ratios for S — quarterly report dated 2025-10-31
Total revenue: 258913000
Gross profit: 191062000
Operating income: -70140000
Net income: -60291000
Capital expenditures: 109000
Operating cash flow: 21014000
Depreciation & amortization: 14933000
Net tangible assets: 497735000
Owner earnings: -45467000
Return on net tangible assets (%): -9.13478055591831
Buffett classification: The Gruesome
Stock price: 17.85
Shares outstanding: 336745012
Book value: 1549922000
P/B ratio: 3.878194169900163
Market cap (USD): 6010898464.200001
Debt to equity: 0.006673239040416228
Current ratio: 1.5247353116908982
Quick ratio: 1.5247353116908982
COGS to revenue (%): 26.20610011857265
R&D to revenue (%): 32.1134898595281
SG&A to revenue (%): 68.77059089346615
Free cash flow (dilution-adjusted): -59473000
Buyback yield (%): 0.8193284297400725
Retained earnings: -1967988000
Receivables turnover: 1.3026675924248827
Capitalized R&D asset: 159980460
ROCI (R&D-adjusted, %): -3.317035177240186
Rosenberg metric: 0.11825618591242999
FCF margin (%): -22.970264142781552
Revenue growth (%): 6.907999322826128
Rule of 40 score: -16.062264819955423
Financial ratios for S — quarterly report dated 2026-01-31
Total revenue: 271153000
Gross profit: 196833000
Operating income: -79853000
Net income: -110232000
Capital expenditures: 194000
Operating cash flow: 4371000
Depreciation & amortization: 16883000
Net tangible assets: 394926000
Owner earnings: -93543000
Return on net tangible assets (%): -23.686209568374835
Buffett classification: The Gruesome
Stock price: 13.98
Shares outstanding: 336745012
Book value: 1437145000
P/B ratio: 3.275727409384578
Market cap (USD): 4707695267.76
Debt to equity: 0.010438056006874741
Current ratio: 1.3890104514414527
Quick ratio: 1.3890104514414527
COGS to revenue (%): 27.408879857497425
R&D to revenue (%): 32.95667021939643
SG&A to revenue (%): 69.08387515535509
Free cash flow (dilution-adjusted): -82085000
Buyback yield (%): 2.083184964660284
Retained earnings: -2078220000
Receivables turnover: 0.9379892693692727
Capitalized R&D asset: 171170850
ROCI (R&D-adjusted, %): -4.0129499894810055
Rosenberg metric: 0.06940802924975345
FCF margin (%): -30.272576737118897
Revenue growth (%): 4.727456713258894
Rule of 40 score: -25.54512002386
Financial ratios for S — annual report dated 2026-01-31
Total revenue: 1001278000
Gross profit: 742101000
Operating income: -309044000
Net income: -450735000
Capital expenditures: 713000
Operating cash flow: 76616000
Depreciation & amortization: 54933000
Net tangible assets: 394926000
Owner earnings: -396515000
Return on net tangible assets (%): -100.40235385869758
Buffett classification: The Gruesome
Stock price: 13.98
Shares outstanding: 336745012
Book value: 1437145000
P/B ratio: 3.275727409384578
Market cap (USD): 4707695267.76
Debt to equity: 0.010438056006874741
Current ratio: 1.3890104514414527
Quick ratio: 1.3890104514414527
COGS to revenue (%): 25.884619456334807
R&D to revenue (%): 32.343964413479576
SG&A to revenue (%): 72.63637071822211
Free cash flow (dilution-adjusted): -245901000
Buyback yield (%): 4.248618243618156
Retained earnings: -2078220000
Receivables turnover: 3.4636829378820324
Capitalized R&D asset: 574742420
ROCI (R&D-adjusted, %): -11.294890095252475
Rosenberg metric: 0.4934270155279736
FCF margin (%): -24.558713963554577
Revenue growth (%): 21.889901042167555
Rule of 40 score: -2.6688129213870226
Financial ratios for S32.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.018194444444444447
Shares outstanding: 4476766233
Market cap (USD): 81452274.51708335
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for S32.L — annual report dated 2022-06-30
Total revenue: 6392413793.103449
Gross profit: 3762758620.6896553
Operating income: 2444137931.034483
Net income: 1840689655.1724138
Capital expenditures: 382758620.6896552
Operating cash flow: 2117241379.310345
Depreciation & amortization: 430344827.5862069
Net tangible assets: 7306206896.551724
Owner earnings: 1888275862.0689654
Return on net tangible assets (%): 25.844817821408345
Capex to operating income (%): 15.660270880361175
Buffett classification: The Great
Stock price: 0.02304878048780488
P/E ratio: 0.056057251101337406
Shares outstanding: 4476766233
Book value: 7433793103.4482765
P/B ratio: 0.013880397364270297
Market cap (USD): 103184002.19963416
Debt to equity: 0.16949624269412744
Current ratio: 2.2351080653663677
Quick ratio: 1.7174486030574592
Effective tax rate (%): 27.72813430815056
Interest coverage ratio: 23.315789473684212
COGS to revenue (%): 41.137123745819395
Free cash flow (dilution-adjusted): 1690344827.586207
Buyback yield (%): 85.55188807095767
Retained earnings: 621379310.3448277
Inventory turnover: 3.8828920570264764
Receivables turnover: 14.41524105754277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.54463605512847
FCF margin (%): 26.442981982953928
Rule of 40 score: 26.442981982953928
Financial ratios for S32.L — annual report dated 2023-06-30
Total revenue: 3739072847.6821194
Gross profit: 1285430463.576159
Operating income: 395364238.410596
Net income: -114569536.42384106
Capital expenditures: 549006622.5165563
Operating cash flow: 788741721.8543047
Depreciation & amortization: 432450331.1258278
Net tangible assets: 6049006622.516556
Owner earnings: -231125827.81456953
Return on net tangible assets (%): -3.8208889862053868
Capex to operating income (%): 138.86097152428812
Buffett classification: The Gruesome
Stock price: 0.023417721518987345
Shares outstanding: 4476766233
Book value: 6208609271.523178
P/B ratio: 0.016885531101280004
Market cap (USD): 104835664.95000002
Debt to equity: 0.18570666666666671
Current ratio: 2.0762820512820515
Quick ratio: 1.369871794871795
Interest coverage ratio: 2.8840579710144927
COGS to revenue (%): 65.62167906482466
Free cash flow (dilution-adjusted): 141721854.30463576
Buyback yield (%): 137.71158984493312
Retained earnings: -179470198.6754967
Inventory turnover: 3.3620689655172415
Receivables turnover: 14.29367088607595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.59089510919717
FCF margin (%): 3.790294013460857
Revenue growth (%): -41.50765315417982
Rule of 40 score: -37.71735914071896
Financial ratios for S32.L — annual report dated 2024-06-30
Total revenue: 3282000000
Gross profit: 1106000000
Operating income: 84000000
Net income: -135333333.33333334
Capital expenditures: 694666666.6666666
Operating cash flow: 746000000
Depreciation & amortization: 428666666.6666667
Net tangible assets: 5826000000
Owner earnings: -401333333.33333325
Return on net tangible assets (%): -6.888660029751686
Capex to operating income (%): 826.9841269841269
Buffett classification: The Gruesome
Stock price: 0.023037974683544304
Shares outstanding: 4476766233
Book value: 5980666666.666666
P/B ratio: 0.017244837889867352
Market cap (USD): 103135627.14
Debt to equity: 0.17456247909932004
Current ratio: 2.385574837310195
Quick ratio: 1.8514099783080262
Interest coverage ratio: 0.5338983050847458
COGS to revenue (%): 66.30103595368678
Free cash flow (dilution-adjusted): -16000000
Buyback yield (%): 22.62393120629385
Retained earnings: -425333333.3333333
Inventory turnover: 3.313705583756345
Receivables turnover: 12.36934673366834
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.016047092976373
FCF margin (%): -0.4875076173065204
Revenue growth (%): -12.224229543039323
Rule of 40 score: -12.711737160345843
Financial ratios for S32.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5555900621.118012
Buffett classification: The Gruesome
Stock price: 0.020124999999999997
Shares outstanding: 4476766233
Book value: 5700621118.012423
P/B ratio: 0.01580440421736666
Market cap (USD): 90094920.43912499
Debt to equity: 0.1794508607539769
Current ratio: 2.8307567127746136
Quick ratio: 1.9820992676973148
Buyback yield (%): 0
Retained earnings: -259627329.19254658
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for S32.L — annual report dated 2025-06-30
Total revenue: 3777777777.7777777
Gross profit: 1647712418.3006535
Operating income: 616339869.2810458
Net income: 139215686.2745098
Capital expenditures: 560130718.9542483
Operating cash flow: 872549019.6078432
Depreciation & amortization: 333986928.10457516
Net tangible assets: 5652941176.470588
Owner earnings: -86928104.57516336
Return on net tangible assets (%): -1.5377500289050752
Capex to operating income (%): 90.88016967126191
Buffett classification: The Gruesome
Stock price: 0.01849315068493151
P/E ratio: 0.5946852308355202
Shares outstanding: 4476766233
Book value: 5788888888.888889
P/B ratio: 0.014301451300436465
Market cap (USD): 82789512.5280822
Debt to equity: 0.1844868465620413
Current ratio: 2.425925925925926
Quick ratio: 1.8288633461047255
Effective tax rate (%): 49.11147011308562
Interest coverage ratio: 4.555555555555556
COGS to revenue (%): 56.3840830449827
Free cash flow (dilution-adjusted): 203921568.62745097
Buyback yield (%): 44.210076943172375
Retained earnings: -472549019.6078431
Inventory turnover: 3.4855614973262035
Receivables turnover: 14.166666666666666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.7542965216676265
FCF margin (%): 5.397923875432526
Revenue growth (%): 15.105965197372873
Rule of 40 score: 20.5038890728054
Financial ratios for S32.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5652941176.470588
Buffett classification: The Gruesome
Stock price: 0.01849315068493151
Shares outstanding: 4476766233
Book value: 5788888888.888889
P/B ratio: 0.014301451300436465
Market cap (USD): 82789512.5280822
Debt to equity: 0.1844868465620413
Current ratio: 2.425925925925926
Quick ratio: 1.8288633461047255
Buyback yield (%): 0
Retained earnings: -472549019.6078431
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 505.1
Shares outstanding: 8345442
Market cap (USD): 4215282754.2000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAM — annual report dated 2022-12-31
Total revenue: 2222667000
Gross profit: 861986000
Operating income: 126052000
Net income: 67263000
Capital expenditures: 88506000
Operating cash flow: 199945000
Depreciation & amortization: 81356000
Net tangible assets: 879696000
Owner earnings: 60113000
Return on net tangible assets (%): 6.83338335061203
Capex to operating income (%): 70.21387998603751
Buffett classification: The Good
Stock price: 329.52
P/E ratio: 40.88414206681236
Shares outstanding: 8345442
Book value: 1068549000
P/B ratio: 2.573574115777564
Market cap (USD): 2749990047.8399997
Debt to equity: 0.050666838862794314
Current ratio: 2.072135978890374
Quick ratio: 1.3453910812808725
Effective tax rate (%): 26.43707073800254
COGS to revenue (%): 55.264598790552064
SG&A to revenue (%): 33.110402952848986
Free cash flow (dilution-adjusted): 95375000
Buyback yield (%): 0
Retained earnings: 439121000
Inventory turnover: 8.27448972718087
Receivables turnover: 33.27445432497979
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.361806682416692
FCF margin (%): 4.291016153116954
Rule of 40 score: 4.291016153116954
Financial ratios for SAM — annual report dated 2023-12-31
Total revenue: 2133292000
Gross profit: 852369000
Operating income: 121823000
Net income: 76250000
Capital expenditures: 62378000
Operating cash flow: 265151000
Depreciation & amortization: 88141000
Net tangible assets: 905756000
Owner earnings: 102013000
Return on net tangible assets (%): 11.26274625837422
Capex to operating income (%): 51.20379567076825
Buffett classification: The Good
Stock price: 345.59
P/E ratio: 37.82427935449181
Shares outstanding: 8345442
Book value: 1077929000
P/B ratio: 2.6755948682890986
Market cap (USD): 2884101300.7799997
Debt to equity: 0.042000911006197995
Current ratio: 2.2549801153667013
Quick ratio: 1.7364883021031134
Effective tax rate (%): 30.421214001533016
COGS to revenue (%): 54.20055013565887
SG&A to revenue (%): 34.245007247015415
Free cash flow (dilution-adjusted): 184093000
Buyback yield (%): 3.220309909880128
Retained earnings: 421568000
Inventory turnover: 9.98726818861047
Receivables turnover: 31.04866973278221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.095508015629338
FCF margin (%): 8.629526572077333
Revenue growth (%): -4.021070182802912
Rule of 40 score: 4.608456389274421
Financial ratios for SAM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 289.14
Shares outstanding: 8345442
Market cap (USD): 2413001099.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 299.98
Shares outstanding: 8345442
Market cap (USD): 2503465691.1600003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SAM — annual report dated 2024-12-31
Total revenue: 2137802000
Gross profit: 893732000
Operating income: 151793000
Net income: 59695000
Capital expenditures: 76254000
Operating cash flow: 248892000
Depreciation & amortization: 93992000
Net tangible assets: 787212000
Owner earnings: 77433000
Return on net tangible assets (%): 9.836359201841436
Capex to operating income (%): 50.23551810689557
Buffett classification: The Good
Stock price: 299.98
P/E ratio: 41.93761104213083
Shares outstanding: 8345442
Book value: 916187000
P/B ratio: 2.732483315262059
Market cap (USD): 2503465691.1600003
Debt to equity: 0.03922779956493598
Current ratio: 1.801549028834904
Quick ratio: 1.2957444879527176
Effective tax rate (%): 31.856578616926555
COGS to revenue (%): 52.35255650429741
SG&A to revenue (%): 34.70569304360273
Free cash flow (dilution-adjusted): 153661000
Buyback yield (%): 9.531346918097222
Retained earnings: 240315000
Inventory turnover: 9.552778702447101
Receivables turnover: 31.390256078938094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.905208127739009
FCF margin (%): 7.187803173539925
Revenue growth (%): 0.21141034607545522
Rule of 40 score: 7.3992135196153805